Moderna

MRNA | NASDAQ | 113 Sledující

$26.56

-1.37%

-$0.37

Sledovat

Overview Metrics Financials

Breakdown	12/31/2024 USD	12/31/2023 USD	12/31/2022 USD	12/31/2021 USD
Total revenue	3,236,000 -52.75%	6,848,000 -64.45%	19,263,000 +8.61%	17,736,000 -
Cost of revenue	1,464,000 -68.80%	4,693,000 -13.35%	5,416,000 +106.95%	2,617,000 -
Gross profit	1,772,000 -17.77%	2,155,000 -84.44%	13,847,000 -8.41%	15,119,000 -
Operating expense	5,717,000 -9.25%	6,300,000 +42.31%	4,427,000 +142.84%	1,823,000 -
Operating income	-3,945,000 +6.94%	-4,239,000 -145.00%	9,420,000 -29.15%	13,296,000 -
Pretax Income	-3,607,000 +8.50%	-3,942,000 -141.17%	9,575,000 -27.93%	13,285,000 -
Tax Provision	-46,000 -105.96%	772,000 -36.36%	1,213,000 +12.00%	1,083,000 -
Net income	-3,561,000 +24.46%	-4,714,000 -156.37%	8,362,000 -31.47%	12,202,000 -
EPS	-9.27 +24.88%	-12.34 -158.15%	21.22 -29.92%	30.28 -
Diluted EPS	-9.27 +24.88%	-12.34 -161.39%	20.1 -29.00%	28.31 -
Average Shares	384,000 +0.52%	382,000 -3.05%	394,000 -2.23%	403,000 -
Diluted Average Shares	384,000 +0.52%	382,000 -8.17%	416,000 -3.48%	431,000 -
EBIT	-3,583,000 +8.22%	-3,904,000 -140.65%	9,604,000 -27.77%	13,296,000 -
EBITDA	-3,394,000 -3.38%	-3,283,000 -133.61%	9,768,000 -27.79%	13,528,000 -

Soubory cookie používáme ke zlepšení prohlížení na webu.